HealthScreen Sydney Opens Australia’s Most Advanced Preventative Health Facility
SYDNEY, Nov. 18, 2025 /PRNewswire/ -- HealthScreen has officially opened its new Sydney facility, expanding the organisation's preventative health and executive services following strong demand at its flagship Melbourne centre. The new location brings together advanced multi-modal imaging, genetics, biomarker analysis and AI-enabled diagnostics to support earlier detection of disease and more personalised long-term health management. HealthScreen...
More countries now require tobacco plain packaging and graphic health warnings on cigarette packages
Canadian Cancer Society report highlights global progress on key tobacco control measures TORONTO, Nov. 18, 2025 /PRNewswire/ -- An international report released today by the Canadian Cancer Society (CCS) reveals ongoing progress for tobacco plain packaging and graphic picture warnings worldwide. The CCS report, titled Cigarette Package Health Warnings: International Status Report, details global developments on plain packaging, ranks 212 countries and territories...
Taiwan’s CMUH Completes HIMSS “Grand Slam,” Achieving DIAM Stage 7 Certification
TAICHUNG, Nov. 18, 2025 /PRNewswire/ -- China Medical University Hospital (CMUH) has secured one of the world's highest honors in digital health, becoming the first hospital in Taiwan to achieve Stage 7 certification under the HIMSS Digital Imaging Adoption Model (DIAM). The designation, awarded by the U.S.-based Healthcare Information and Management Systems Society (HIMSS), represents the pinnacle of excellence...
MindHYVE’s ChironAI™ Showcased at Peshawar Institute of Cardiology’s CME on Cardiovascular Imaging Innovation”
PESHAWAR, Pakistan, Nov. 18, 2025 /PRNewswire/ -- The Peshawar Institute of Cardiology – Medical Teaching Institute (PIC-MTI) hosted a high-profile Radiology Continuing Medical Education (CME) session on "Innovations in Cardiovascular Imaging," drawing senior cardiologists, radiologists, and imaging specialists from across Pakistan for an exchange on cutting-edge developments in cardiac imaging and diagnostic...
Genesis MedTech and National University Health System Forge Strategic Partnership to Advance AI Innovation for Safer, Smarter Surgical Care
SINGAPORE, Nov. 18, 2025 /PRNewswire/ -- Genesis MedTech Group and the National University Health System (NUHS) have formed a strategic partnership to advance artificial intelligence (AI) in surgery and medical device innovation. This partnership stems from a Memorandum of Understanding signed earlier this year, with further details unveiled at the World Congress...
European Union and Vietnam: A joint path to poultry farming based on immunity and prevention
HANOI, Vietnam, Nov. 18, 2025 /PRNewswire/ -- To mark the World Antimicrobial Resistance (AMR) Awareness Week, which begins today (18–24 November), the EU co-financed the 'European Poultry – From Our Farms to Your Tables' information and promotional campaign to highlight Vietnam's progress in the rational use of antibiotics in poultry production and the compatibility...
Canary Speech Receives Frost & Sullivan’s 2025 North America Technology Innovation Leadership Recognition for Technology Innovation Leadership
Recognized for transforming Intelligent Vocal Biomarker Diagnostics through innovative AI-powered, smartphone-based diagnostic solutions SAN ANTONIO, Nov. 17, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Canary Speech, a global leader in AI-powered vocal biomarker technology, has received the 2025 North America Technology Innovation Leadership recognition in the intelligent vocal biomarker diagnostics industry for its outstanding achievements in technology...
Ajinomoto Bio-Pharma Services Wins “Best ADC Preclinical Publication 2024” Award for AJICAP® Technology at 2025 World ADC Awards
Recognition underscores Ajinomoto Bio-Pharma Services' innovation and scientific excellence in advancing next-generation antibody-drug conjugate technologies TOKYO, Nov. 17, 2025 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, today announced it has been named the winner of the "Best ADC Preclinical Publication 2024" at the...
Bambusa Therapeutics Announces Completion of Series A-2 Financing to Accelerate Next-Generation Bispecific Programs
BOSTON, Nov. 17, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. ("Bambusa"), a clinical-stage biotechnology company pioneering next-generation bispecific antibodies for immunology and inflammation (I&I), today announced the completion of its oversubscribed Series A-2 financing, closed at a substantial valuation step-up over the prior round. This Series A-2 financing reflects strong participation from...
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
SHANGHAI and JERSEY CITY, N.J., Nov. 17, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY® (pertuzumab-dpzb) 420 mg/14 mL injection for intravenous use, an interchangeable biosimilar to PERJETA (pertuzumab), for all indications of the reference product. POHERDY...
